Ingevity Corporation growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: -10.3%
EBITDA: +107.2%
EBIT: -0.1%
EPS: +64.1%
Free cash flow: +158.5%
Operating cash flow: +82.9%

Forward estimates

Revenue: +1.8%
EBITDA: +268.8%
EPS: +265.4%

Three-year CAGR

Revenue: -11.2%
EBITDA: -56.0%
EBIT: -8.4%
Net income: +61.2%
EPS: +61.1%
Free cash flow: +17.0%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.